RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.12B
AUM Growth
+$2.18B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$98.6M
2
+$57.4M
3
+$55.6M
4
LBRX
LB Pharmaceuticals
LBRX
+$28.2M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$25.4M

Top Sells

1
+$92.5M
2
+$48.1M
3
+$40.6M
4
ELVN icon
Enliven Therapeutics
ELVN
+$17M
5
HNGE
Hinge Health
HNGE
+$15.5M

Sector Composition

1 Healthcare 99.83%
2 Financials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELDN icon
51
Eledon Pharmaceuticals
ELDN
$209M
$9.24M 0.11%
3,566,338
JBIO
52
Jade Biosciences
JBIO
$731M
$9.17M 0.11%
1,062,326
SABS icon
53
SAB Biotherapeutics
SABS
$195M
$8.85M 0.11%
+4,401,500
INSP icon
54
Inspire Medical Systems
INSP
$1.84B
$8.53M 0.11%
+114,901
CTMX icon
55
CytomX Therapeutics
CTMX
$910M
$8.49M 0.1%
2,661,331
AVTX icon
56
Avalo Therapeutics
AVTX
$324M
$8.43M 0.1%
662,968
-270,005
PCSC
57
Perceptive Capital Solutions
PCSC
$141M
$7.95M 0.1%
750,000
SRZN icon
58
Surrozen
SRZN
$238M
$7.76M 0.1%
602,626
WGS icon
59
GeneDx Holdings
WGS
$2.3B
$6.25M 0.08%
58,044
ACET icon
60
Adicet Bio
ACET
$69.6M
$6.11M 0.08%
471,313
NAMSW icon
61
NewAmsterdam Pharma Warrant
NAMSW
$5.7M 0.07%
333,333
EVH icon
62
Evolent Health
EVH
$363M
$4.9M 0.06%
+579,052
GKOS icon
63
Glaukos
GKOS
$6.99B
$4.42M 0.05%
+54,180
DSGN icon
64
Design Therapeutics
DSGN
$595M
$3.58M 0.04%
+475,699
EXAS icon
65
Exact Sciences
EXAS
$19.7B
$3.01M 0.04%
+54,939
IFRX icon
66
InflaRx
IFRX
$62.3M
$2.64M 0.03%
1,973,233
PGNY icon
67
Progyny
PGNY
$1.53B
$2.08M 0.03%
+96,628
ACHC icon
68
Acadia Healthcare
ACHC
$2.12B
– –
-89,262
DYN icon
69
Dyne Therapeutics
DYN
$2.57B
– –
-9,714,392
ELVN icon
70
Enliven Therapeutics
ELVN
$1.76B
– –
-848,986
RXST icon
71
RxSight
RXST
$308M
– –
-3,702,967
TXG icon
72
10x Genomics
TXG
$2.94B
– –
-475,343
MBX
73
MBX Biosciences
MBX
$1.46B
– –
-377,841
BBNX
74
Beta Bionics
BBNX
$561M
– –
-500,000
HNGE
75
Hinge Health
HNGE
$3.37B
– –
-300,000
1 2
3
4